London-headquartered healthcare company, which has served over 20 Lakh patients globally, launches Voy India to make evidence-based obesity treatment accessible nationwide New Delhi, India, 5th June, 2026. Voy, the London-headquartered digital healthcare company and market leader in GLP-1 obesity care in the UK, Germany, and Brazil, today announced its entry into India through the 100% acquisition …



